Commonly used blood-based biomarkers for lung cancer diagnosis, such as carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), neuron-specific enolase (NSE), and pro-gastrin-releasing peptide (ProGRP), have been extensively applied. This evidence concerns the gene CEACAM5 and lung carcinoma.